Loading data
BNCNasdaq
| Unit: USD | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 2.8 m USD | 6.91 m USD | 11.28 m USD | 13.64 m USD |
| Cost of revenue | — | 3.02 m USD | 6.37 m USD | 10.14 m USD | 10.71 m USD |
| Gross profit | — | -219.62 k USD | 542.08 k USD | 1.14 m USD | 2.93 m USD |
| Research and development expense | — | — | 76.49 k USD | 319.99 k USD | 469.7 k USD |
| Selling, general and administrative expense | — | 2.94 m USD | 3.15 m USD | 4.76 m USD | 3.66 m USD |
| Operating profit | — | -3.17 m USD | -2.95 m USD | -5.72 m USD | -1.98 m USD |
| Profit before tax | — | -3.15 m USD | -2.91 m USD | -5.5 m USD | -1.34 m USD |
| Net income (reported basis) | 100 k USD | -3.1 m USD | -2.91 m USD | -5.5 m USD | -1.34 m USD |
| Net income attributable to common shareholders | — | — | -2.91 m USD | -5.97 m USD | -3.69 m USD |
| Basic earnings per share | — | -4.22 USD/share | -4.33 USD/share | -0.84 USD/share | -2.33 USD/share |
| Diluted earnings per share | — | -4.22 USD/share | -4.33 USD/share | -0.84 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.